The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Castlight Health Inc

NYSE: CSLT
Last

(U.S.) $4.15

Today's change-0.10 -2.35%
Updated September 22 9:41 AM EDT. Delayed by at least 15 minutes.
 

Castlight Health Inc

NYSE: CSLT
Last

(U.S.) $4.15

Today's change-0.10 -2.35%
Updated September 22 9:41 AM EDT. Delayed by at least 15 minutes.

Sharp drop following new 20-day high

Castlight Health Inc is sharply lower today, dropping (U.S.)$0.10 or 2.35% to (U.S.)$4.15 after setting a new 20-day high. Over the last five days, shares have gained 2.47%, but are down 16.16% for the last year to date. Shares have underperformed the S&P 500 by 16.02% during the last year.

Key company metrics

  • Open(U.S.) $4.20
  • Previous close(U.S.) $4.25
  • High(U.S.) $4.25
  • Low(U.S.) $4.15
  • Bid / Ask(U.S.) $4.15 / (U.S.) $4.25
  • YTD % change-16.16%
  • Volume8,827
  • Average volume (10-day)301,222
  • Average volume (1-month)266,811
  • Average volume (3-month)329,505
  • 52-week range(U.S.) $3.05 to (U.S.) $5.50
  • Beta1.67
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.44
Updated September 22 9:41 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.05%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue32283026
Total other revenue--------
Total revenue32283026
Gross profit20202118
Total cost of revenue12888
Total operating expense51433937
Selling / general / administrative23232118
Research & development15111011
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-19-15-9-12
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-19-15-9-11
Income after tax-14-15-9-11
Income tax, total-5------
Net income-14-15-9-11
Total adjustments to net income--------
Net income before extra. items-14-15-9-11
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-14-15-9-11
Inc. avail. to common incl. extra. items-14-15-9-11
Diluted net income-14-15-9-11
Dilution adjustment--------
Diluted weighted average shares131105104103
Diluted EPS excluding extraordinary itemsvalue per share-0.11-0.14-0.09-0.11
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.11-0.14-0.09-0.11